Latest Breaking News On - Christine cassianochief communications - Page 1 : comparemela.com

Allogene Therapeutics Announces Oral Presentation of Phase 1 Data on ALLO-501/501A in Large B Cell Lymphoma at the International Conference on Malignant Lymphoma (ICML) Lugano

Allogene Therapeutics Announces Oral Presentation of Phase 1 Data on ALLO-501/501A in Large B Cell Lymphoma at the International Conference on Malignant Lymphoma (ICML) Lugano
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMadeleine goldsteinmanagerAllogene alloFrederick lockeAmerican society of clinical oncologyMoffitt cancer center tampaInternational conference on malignant lymphomaChristine cassianochief communicationsAllogene therapeutics incDepartment of bloodCorporate pipeline communicationsDrug administrationLong term follow up dataDemonstrates potentialGenerate durable complete responses similarApproved autologous

Allogene Therapeutics Announces Participation in Four Upcoming Investor Conferences

Allogene Therapeutics Announces Participation in Four Upcoming Investor Conferences
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Canaccord genuityAllogene therapeutics incSecurities life sciences conferencemondayChristine cassianochief communicationsHealth care conferencewednesdayWall streetOncology virtualthursdayCare conferencewednesdayLife sciences conferencemondayMarkets global healthcare conferencetuesdayAllogene therapeuticsallogene therapeuticsSouth san franciscoForward looking statementsPrivate securities litigation reform actAllogene therapeuticsInvestor contact

Allogene Therapeutics Announces Participation in Two Upcoming Investor Conferences

Allogene Therapeutics Announces Participation in Two Upcoming Investor Conferences
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Jessica bernsteinseniorHealth care conferencemondayAllogene therapeutics incChristine cassianochief communicationsWall streetAnnual health care conferencemondayAnnual healthcare conferencetuesdayAllogene therapeuticsallogene therapeuticsSouth san franciscoForward looking statementsPrivate securities litigation reform actAllogene therapeuticsInvestor contactChristine cassianochief communications officerBernsteinsenior manager

Allogene Therapeutics (ALLO) Announces Publication of Industry-Advancing Case Study on Chromosomal Rearrangement

Allogene Therapeutics (ALLO) Announces Publication of Industry-Advancing Case Study on Chromosomal Rearrangement
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Allogene alloDavid changExchange commissionAllogene therapeutics incDrug administrationChristine cassianochief communicationsCompany alloWall streetMolecular therapyChief executive officerAllogene therapeuticsallogene therapeuticsSouth san franciscoForward looking statements thisPrivate securities litigation reform actAllogene therapeuticsInvestor contact

Allogene Therapeutics Presents Data on Dagger™, a Next Generation AlloCAR T™ Platform Technology

Allogene Therapeutics Presents Data on Dagger™, a Next Generation AlloCAR T™ Platform Technology
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Barbra sasuAllogene alloAllogene therapeutics incDagger technologyDrug administrationChristine cassianochief communicationsEmerging cellular therapiesChief scientific officerFast track designationAllogene therapeuticsallogene therapeuticsSouth san franciscoForward looking statements thisPrivate securities litigation reform actAllogene therapeuticsInvestor contactChristine cassianochief communications officer